Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2015, Vol. 35 Issue (9): 7-13    DOI: 10.13523/j.cb.20150902
    
The Efficacy of PolyI:C and IL-15 as Adjuvant the Murine Zona Pellucid 3 DNA Vaccine Intranasally Immunized
WANG Dan-yang1, YANG Yu1, YANG Xiu-mei1, ZHANG Fu-chun1, WU Dao-cheng2, ZHANG Ai-lian1
1 College of Life Science and Technology, Xinjiang University, Urumqi 830046, China;
2 School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, China
Download: HTML   PDF(931KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Aim:To observe the adjuvant efficacy of murine zona pellucid 3(mZP3) DNA vaccine through intranasal vaccination with PolyI:C and IL-15, and chitosan as delivery vector. Methods: Mice were delivered with chitosan-loaded mZP3 DNA vaccine or added PolyI:C and IL-15 by intranasal route, and to detect specific IgG antibody level in serum, sIgA in vaginal fluid and lung fluid by indirect ELISA, to detect lymphocyte proliferation by MTT, to do histology analysis of mice ovary for morphology of ovary. Results: PolyI:C and IL-15 can promote IgG antibody level of immunized mZP3 mice, promote lymphocyte proliferation and ovarian abnormalities in mice. Conclusion: The results suggest that antagonist of TLR PolyI:C and IL-15 have a synergistic effect and may be enhance the immunity effect of mZP3 DNA vaccine and reduce murine fertility rate to some extent.



Key wordsPolyI:C      IL-15      DNA vaccine      Adjuvant     
Received: 10 April 2015      Published: 25 September 2015
ZTFLH:  R392.12  
Cite this article:

WANG Dan-yang, YANG Yu, YANG Xiu-mei, ZHANG Fu-chun, WU Dao-cheng, ZHANG Ai-lian. The Efficacy of PolyI:C and IL-15 as Adjuvant the Murine Zona Pellucid 3 DNA Vaccine Intranasally Immunized. China Biotechnology, 2015, 35(9): 7-13.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20150902     OR     https://manu60.magtech.com.cn/biotech/Y2015/V35/I9/7


[1] Lloyd M L, Papadimitriou J M, Robertson S A, et al. Immunoglobulin to zona pellucida 3 mediates ovarian damage and infertility after contraceptive vaccination in mice. Journal of Autoimmunity, 2010, 35(1): 77-85.

[2] Gupta S K, Srivastava N, Choudhury S, et al. Update on zona pellucida glycoproteins based contraceptive vaccine. J Reprod Immunol, 2004, 62(17): 79-89.

[3] 侯俊玲, 郑亚东, 骆学农, 等. DNA疫苗安全性的研究进展. 细胞与分子免疫学杂志, 2009,25(5):470-472. Hou J L, Zheng Y D, Luo X N, et al. Advances in DNA vaccine safety. Chinese Journal of Cellular and Molecular Immunology,2009,25(5):470-472.

[4] McGhee J R, Mestecky J, Dertzbaugh M T, et al. The mucosal immune system from fundamental concepts to vaccine development. Vaccine, 1992, 10(2):75-88.

[5] Illum L, Jabbal-Gill I, Hinchcliffe M, et al. Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev, 2001, 51(1-3):81-96.

[6] Ichinohe T, Ainai A, Tashiro M, et al. PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants. Vaccine, 2009,27(45):6276-6279.

[7] Zhu Q, Egelston C, Gagnon S, et al. Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. The Journal of Clinical Investigation, 2010,120(2):607-616.

[8] Oh S, Perera L P, Burke D S, et al. IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci USA, 2004,101(42):15154-15159.

[9] Sui Y J, Zhu Q, Gagnon S, et al. Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Microbiology, 2010,107(21):9843-9848.

[10] 邢雅玲, 任乐宁, 陈晓娟, 等. 人Toll样受体靶向药物研究进展.中国生物工程杂志, 2010,30(10):60-65. Xing Y L, Ren L N, Chen X J, et al. Developm ent of potential therapeutics targeting to human tolllike receptor.China Biotechnology,2010,30(10):60-65.

[11] 张爱莲, 赵干, 王宾, 等. 草原兔尾鼠GST-LZP3融合蛋白的原核表达及其抗体制备. 细胞与分子免疫学杂志, 2004, 20 (2):168-170. Zhang A L, Zhao G,Wang B, et al. Expression of Lagurus ZP3 fusion protein in prokaryotic cells and preparation of its antiserum. Chinese Journal of Cellular and Molecular Immunology.2004, 20 (2):168-170.

[12] Li J Y, Jin H L, Zhang A L, et al. Enhanced contraceptive response by co-immunization of DNA and protein vaccines encoding the mouse zona pellucida 3 with minimal oophoritis in mouse ovary. J Gene Med, 2007, 9(1): 1095-1103.

[13] Kasamatsu J, Takahashi S, Azuma M, et al. PolyI:C and mouse surviv in artificially embedding human 2B peptide induce a CD4+ T cell response to autologous survivin in HLA-A*2402 transgenic mice. Immunobiology, 2015, 220(1):74-82.

[14] 刘赋佩, 常丹, 喻艳坤, 等. IL-15增强小鼠卵透明带3DNA疫苗的滴鼻免疫效果. 细胞与分子免疫学杂志, 2012,28(1):25-28. Liu F P, Chang D, Yu Y K, et al. The efficacy of enhancing murine zona pellucid 3 DNA vaccine immunized through intranasal vaccination by IL-15.Chinese Journal of Cellular and Molecular Immunology,2012,28(1):25-28.

[15] Wang X, Zhang X Y, Kang Y M, et al. Interleukin-15 enhances DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine, 2008, 26(40):5135-5144.

[16] Tounsi N, Meghari S, Moser M, et al. Lysophosphatidylcholine exacerbates Leishmania major-dendritic cell infection through interleukin-10 and a burst in arginase1 and indoleamine 2,3-dioxygenase activities. International Immunopharmacology, 2015,25(1):1-9.

[17] Zhang A L, Li J Y, Zhao G, et al. Intranasal co-administration with the mouse zona pellucida 3 expressing construct and its coding protein induces contraception in mice. Vaccine, 2011,29(39):6785-6792.

[1] CHENG Xu,YANG Yu-qing,WU Sai-nan,HOU Qin-long,LI Yong-mei,HAN Hui-ming. Construction of DNA Vaccines of Staphylococcus aureus SarA, IcaA and Their Fusion Genes and Preliminary Study in Mouse Immune Response[J]. China Biotechnology, 2020, 40(7): 41-50.
[2] QIAN Ying,QIAN Chen,BAI Xiao-qing,WANG Jing-jing. Application of Adjuvant in Cancer Immunotherapy[J]. China Biotechnology, 2020, 40(3): 96-103.
[3] Lin YANG,Zhe-yan FU,Zheng-bing LV,Jian-hong SHU. Classification and Mechanism of Immune Adjuvant[J]. China Biotechnology, 2019, 39(5): 114-119.
[4] SUN Si,QIU Yu-lan,YAN Ju-rong,YANG Jing,WU Guang-ying,WANG Lin,XU Wen-chun. Recombinant Plasmid pcDNA3-dnaJ Prime/DnaJ Protein Boost Immunization Induce Th1/Th17 Immune Responses and Protect Mice Against Pneumococcal Infection[J]. China Biotechnology, 2019, 39(12): 9-17.
[5] FENG Xue-jun, LONG Qiong, TANG Zeng-hua, HUANG Wei-wei, LIU Cun-bao, YANG Xu, SUN Wen-jia, BAI Hong-mei, MA Yan-bing. The Prokaryotic Expression of Recombinant Murine Interlukin (IL)-33 and Its Mucosal Immunization Affect as Adjuvant[J]. China Biotechnology, 2017, 37(4): 26-32.
[6] FU Xi-zong, BAI Qin-qin, CHEN Li-li. Adjuvant Applications in Chlamydial Vaccine[J]. China Biotechnology, 2016, 36(10): 101-105.
[7] MAN Chao-lai, CHANG Yang, TANG Gao-xia, ZHAO Li, LI Feng, ZHEN Xin, MI Xiao-ju. Research Progress of Genetic Adjuvant[J]. China Biotechnology, 2013, 33(7): 112-117.
[8] LI Yan-hong, LI Xiao-bo, LU Xue-ying, GAO Jian-feng, XIAO Xiang-wen. Immunoadjuvant Effect of Ursolic Acid for Murine H22 Hepatocarcinoma Cell Vaccine[J]. China Biotechnology, 2013, 33(10): 28-35.
[9] CHEN Ao, YU Yun-zhou, WANG Wen-bin, PANG Xiao-bin, WANG Shuang, YU Wei-yuan, SUN Zhi-wei. The Immunological Character of Polypeptide B Cell Epitopes Vaccines of Alzheimer's Disease in Different Adjuvants[J]. China Biotechnology, 2011, 31(8): 18-23.
[10] LOU Yao-xian, ZOU Qiang, JIN Jin, WANG Xian-zheng, ZHANG Yi-zhi, WANG Bin. IL-17 as an Adjuvant Enhances Immune Responses of Recombinant Protein Vaccine[J]. China Biotechnology, 2011, 31(7): 20-26.
[11] ZHANG Ping-jing, LI Zhong-ming, LIU Qing-liang. The Development of a Modified and Simple Process for the Purification of Plasmid DNA[J]. China Biotechnology, 2011, 31(04): 106-112.
[12] SUN Ying-jun, ZHANG Yan, WU Qiong, ZHENG Hai-xue, ZHANG Zhi-dong. The Progress of Study on Innate Immunity Led to the Design and Development of More Specific and Focused Adjuvants[J]. China Biotechnology, 2011, 31(03): 87-90.
[13] ZHONG Yi-wei, LI Jin-yao, GENG Shuang, WANG Bin. Examination DNA Vaccine-binding Proteins in the Immune Cells[J]. China Biotechnology, 2010, 30(10): 12-16.
[14] . Examination DNA vaccine-binding proteins in the immune cells[J]. China Biotechnology, 2010, 30(10): 0-0.
[15] . Research in Bacterial Ghost as DNA VaccineDelivery System[J]. China Biotechnology, 2010, 30(07): 0-0.